« Return to News | CROs/Service Providers

Top Stories for the Week of Oct. 8th 2007

Friday, October 12, 2007 11:29 AM

Top News

 

Parexel Acquires Taiwan-based CRO APEX Clinical Research

Waltham, Mass.-based contract research organization (CRO) Parexel International purchased APEX Clinical Research, a CRO based in Taiwan with operations throughout the Asia-Pacific region. The company paid $50.9 million in cash for the remaining 20.3 million shares of APEX. The newly acquired company will become a wholly owned subsidiary and will be called Parexel APEX International. Parexel had already purchased a minority interest in the CRO in April 2003.

DSG Takes on EDC, Randomization and Supply Integration

DSG has replaced the need to use an interactive voice response system (IVRS) for complex randomization to obtain drug kit numbers, thus cutting out a third technology vendor. By using eSourcing on a tablet PC and DSG’s eCaseLink EDC system, site investigators were able to record patient information in real time and receive randomized and blinded kit numbers for drugs already shipped from the sponsor. This also eliminated the need to reconcile the IVRS data with a site’s main trial management system.

Other breaking news...      

Company Profile: An interview with Kathleen Ashenfelter, director, operations and development, Cu-Tech

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.